Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

Janus kinase inhibitors show promise in treating autoimmune skin diseases.

Anifrolumab effectively improved symptoms and reduced steroid use in Japanese patients with systemic lupus erythematosus.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Long-term use of azole antifungals can cause hair loss, hormonal imbalances, and severe skin reactions.

Tadalafil and Finasteride may help treat aggressive melanoma.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Olanzapine reduces stress-related anxiety in rats when given acutely.

Stopping leflunomide healed the woman's skin ulcers.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Cialis and Finasteride could be repurposed to treat aggressive melanoma.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Baricitinib improved hair loss and arthritis in a lupus patient.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

A patient with complete hair loss regrew all her hair using tofacitinib.